Since our study demonstrated higher expression of TIMP-2 in high-grade serous ovarian tumours, we used normal secretory Fallopian tube and cancer cell lines that expressed relatively more TIMP-2 than TIMP-1 or TIMP-3, to investigate in vitro the cellular functions of TIMP-2 by transient knockdown. The gene discussed is TIMP3; the disease is cancer.